Mechanism of Action of Pertuzumab and Herceptin in Ovarian Cancer Models in Vitro and in Vivo

Project Details

StatusFinished
Effective start/end date1/12/0730/04/11

Funding

  • UK industry, commerce and public corporations: £34,483.00